Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Invitro International (IVRO) -- Ignore unavailable to you. Want to Upgrade?

To: MicroKing who wrote (22)	7/9/1999 12:16:00 AM
From: MicroKing	Read Replies (1) \| Respond to of 74

Part I Here is the bio's for 3 of the 5 directors. Irwin J. Gruverman, Chairman of the board. He founded and serves as Chairman, CEO, and a director of Microfluidics International Corp, a publicly-held supplier of innovative formulation equipment and methodology to the health care, food, cosmetics, home products and process industries. Prior to 1982, Mr. Gruverman was Executive Vice President of the New England Nuclear Division of E. I. DuPont & Company, with responsibility for health care activities, including immunodiagnostics and radiopharmaceuticals. He was responsible for the development and commercial success of Thalluim-201, an imaging agent for diagnosis of heart disease. Mr. Gruverman is a licensed Professional Engineer and holds a B.S. degree in chemical engineering from The Cooper Union, New York, and M.S. degree in Nuclear Engineering from Massachusetts Institute of Technology. W. Rich Ulmer, CEO and President. Mr. Ulmer started his extensive career in the health care and pharmaceutical industry at Merck, Sharp & Dome in 1964. For approximately 25 years from 1967 to 1992, he was employed by Allergan Inc., an integrated specialty pharmaceutical and medical device company headquartered in Southern California. During that period Mr. Ulmer held various key management positions, including marketing and sales management positions for 1967 to 1977. Director of sales and marketing form 1979 to 1981; Senior Vice President of US Operations from 1981 to 1985; President of Allergan Pharmaceuticals from 1985 to 1988; President of Allergan Medical Optics-Surgical Products an Services Division from 1988 to 1990; and President of Herbert Laboratories (Allergan Herbert) from 1991 to 1992. Mr. Ulmer was self- employed as a consultant form 1992 to 1994 and served as President of Wilshire Transdermal, a subsidiary of Wilshire Technologies. William M. Curtis has served as an executive officer and director of the company since its inception in 1985. Mr. Curtis has been principally engaged in a private law practice in Southern California since 1976 specializing in corporate, merger and acquisition, finance and securities matters. He was associated with the New York law firm of Willkie Farr & Gallagher from 1965 through 1970. Mr. Curtis served as vice president, general counsel and a director from 1971 through 1975 of Plant Industries, Inc., a publicly-held company in Anaheim, Calif., and as a director of Brennand-Paige Industries, Inc., a diversified publicly-held company, from 1971 until sale of the company in 1983. Mr. Curtis holds a law degree from Duke University and a B.A. from Wesleyan University, Connecticut.